Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. A, 1999, Pages 49-54

  Shah, Anita ^a   Liu, Ming Chung ^a   Vaughan, David ^b   Heller, Allen H ^a  

^a BAYER CORPORATION   (United States)

^b Bayer Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TABLET;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; FASTING; FOOD-DRUG INTERACTIONS; HUMANS; INTESTINAL ABSORPTION; MALE; SUSPENSIONS; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 0033012939     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Vance Bryan, K., Guay, D. R. & Rotschafer, J. C. (1990). Clinical pharmacokinetics of ciprofloxacin. Clinical Pharmacokinetics 19, 434-61.
2. Crump, B., Wise, R. & Dent, J. (1983). Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 24, 784-6.
3. Davis, R. L., Koup, J. R., Williams-Warren, J., Weber, A. & Smith, A. L. (1985). Pharmacokinetics of three oral formulations of ciprofloxacin. Antimicrobial Agents and Chemotherapy 28, 74-7.
4. Tartaglione, T. A., Raffalovich, A. C., Poynor, W. J., Espinel Ingroff, A. & Kerkering, T. M. (1986). Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses. Antimicrobial Agents and Chemotherapy 29, 62-6.
5. Guay, D. R., Awni, W. M., Peterson, P. K., Obaid, S., Stein, D., Breitenbucher, R. et al. (1988). Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients. International Journal of Clinical Pharmacology, Therapy, and Toxicology 26, 279-84.
6. Ledergerber, B., Bettex, J. D., Joos, B., Flepp, M. & Luthy, R. (1985). Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin. Antimicrobial Agents and Chemotherapy 27, 350-2.
7. Krol, G. J., Beck, G. W. & Benham, T. (1995). HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids. Journal of Pharmaceutical and Biomedical Analysis 14, 181-90.
8. Gibaldi, M. & Perrier, D. (1982). Pharmacokinetics, 2nd edn. Marcel Dekker, New York.